Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
13-May-2026 | 404.3 | 413.3 | 398.15 | 404.05 | 5,347 | 8,09,55,014.9 | 96,659 |
14-May-2026 | 409.95 | 413.6 | 395.5 | 399.5 | 4,963 | 6,63,94,056.25 | 74,560 |
15-May-2026 | 399.5 | 407.4 | 396.65 | 400.4 | 3,256 | 4,49,51,469.3 | 56,065 |
18-May-2026 | 396.2 | 402.2 | 387.1 | 398 | 7,379 | 6,69,61,030.9 | 74,186 |
19-May-2026 | 393.7 | 418.05 | 393.7 | 410.25 | 7,120 | 6,49,86,281.35 | 77,913 |
20-May-2026 | 408 | 426 | 406.75 | 424.3 | 7,323 | 11,78,54,510.3 | 1,66,570 |
21-May-2026 | 428.5 | 432.8 | 422.1 | 425.85 | 5,708 | 10,76,17,844.45 | 1,00,655 |
22-May-2026 | 432.65 | 438.45 | 374 | 381.45 | 43,618 | 84,88,04,105.35 | 5,01,173 |
25-May-2026 | 385 | 389.4 | 361.7 | 369.15 | 19,438 | 33,08,49,212.9 | 3,86,821 |
26-May-2026 | 373.2 | 380.9 | 370 | 376.25 | 8,531 | 14,41,91,809.85 | 1,46,095 |
27-May-2026 | 378.45 | 380.75 | 374.2 | 377.35 | 3,766 | 7,61,69,538.45 | 94,362 |
29-May-2026 | 379.95 | 381.4 | 367.1 | 369.25 | 3,511 | 5,96,11,757.55 | 92,597 |
01-Jun-2026 | 369.25 | 371 | 357.5 | 359.5 | 4,925 | 9,67,98,741.55 | 1,43,050 |
02-Jun-2026 | 359 | 365.9 | 354.1 | 363.95 | 3,429 | 4,47,89,656.6 | 51,343 |
03-Jun-2026 | 364.2 | 364.6 | 352.7 | 356.5 | 4,737 | 5,82,71,721.65 | 74,527 |
04-Jun-2026 | 357.4 | 359.9 | 352 | 353.65 | 2,649 | 3,87,13,179.2 | 61,778 |
05-Jun-2026 | 353.65 | 378.65 | 351 | 369.1 | 6,503 | 12,25,41,358.5 | 1,13,166 |
08-Jun-2026 | 363.25 | 375.95 | 363.25 | 368.8 | 5,141 | 6,80,71,996.55 | 83,650 |
09-Jun-2026 | 367.6 | 389.4 | 367.6 | 377.45 | 8,643 | 12,76,02,577.3 | 1,25,319 |
10-Jun-2026 | 377.9 | 399.9 | 376.25 | 381.55 | 11,035 | 18,30,90,143.35 | 1,66,332 |
11-Jun-2026 | 380.35 | 386.15 | 376.3 | 379.2 | 3,495 | 4,88,25,509.5 | 55,052 |
12-Jun-2026 | 383 | 389.7 | 376.55 | 383.45 | 3,504 | 4,90,88,809.45 | 44,139 |
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
